81_FR_54248 81 FR 54091 - Statement of Organization, Functions, and Delegations of Authority

81 FR 54091 - Statement of Organization, Functions, and Delegations of Authority

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 157 (August 15, 2016)

Page Range54091-54094
FR Document2016-19302

Federal Register, Volume 81 Issue 157 (Monday, August 15, 2016) 
[Federal Register Volume 81, Number 157 (Monday, August 15, 2016)]
[Notices]
[Pages 54091-54094]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-19302]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 81 FR 46677, dated July

[[Page 54092]]

18, 2016) is amended to reflect the reorganization of the Division of 
Tuberculosis Elimination, National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, Office of Infectious Diseases, 
Centers for Disease Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete and replace the title and the mission and function 
statements for the Division of Tuberculosis Elimination (CVJE) and 
insert the following:
    Division of Tuberculosis Elimination (CVJE). The Division of 
Tuberculosis Elimination (DTBE) promotes health and quality of life by 
preventing, controlling, and eventually eliminating tuberculosis (TB) 
from the United States (U.S.), and collaborates with international 
partners by representing the U.S. national TB program. In carrying out 
its mission, the Division conducts the following activities under each 
focus area: (1) Administers and promotes a national program for the 
prevention, control, and elimination of TB; (2) supports a nationwide 
framework for surveillance of TB and evaluation of national TB 
prevention and control performance; (3) provides programmatic 
consultation, technical assistance, and outbreak response assistance to 
state and local TB programs; (4) co-chairs and coordinates 
administrative support for the Federal TB Task Force, and supports and 
collaborates with the National Tuberculosis Controllers Association 
(NTCA) and the Tuberculosis Education and Training Network to promote 
effective national communications and coordinated feedback on urgent 
policy and program performance issues; (5) supports development of TB 
patient education materials and interventions, capacity development, 
and access to medical consultation; (6) provides national and 
supranational reference laboratory function for identification and drug 
susceptibility testing of Mycobacterium tuberculosis; (7) fosters 
patient-centered messages, including those regarding directly-observed 
therapy, to promote adherence with long-term treatment for improvements 
in well-being and interruption in community transmission of M. 
tuberculosis; (8) promotes targeted testing of epidemiologically-
defined at-risk populations and treatment of persons with latent TB; 
(9) conducts epidemiologic, laboratory, behavioral, health systems, and 
clinical research; (10) supports patient and provider research to 
identify barriers and facilitators to TB services; (11) supports 
multicenter consortia for epidemiologic, laboratory, diagnostics, 
clinical, and vaccine development research; (12) develops and applies 
mathematical TB transmission models to forecast future incidence and 
prevalence trends; (13) provides leadership and formulates policies and 
guidelines; (14) provides technical supervision and training to federal 
assignees working in state, and local TB control programs; (15) 
develops training and educational materials, and provides technical 
assistance on communications and training needs; (16) participates in 
the development of policies and guidelines for TB prevention and 
control within populations at high risk, such as persons infected with 
HIV or racial and ethnic minorities; (17) supports technical activities 
and operational research to reduce TB in foreign-born populations; (18) 
Represents the U.S. national TB program with regard to the global 
health initiatives for the prevention and control of TB and drug-
resistant TB; (19) Represents the U.S. national TB control program with 
regard to the World Health Organization (WHO)-hosted Stop TB 
Partnership for implementation of the Global Plan to Stop TB and 
Millennium Development Goals; (20) monitors progress and trends towards 
TB elimination, including progress towards CDC's Healthy People 2020; 
(21) provides progress reports to, and solicits advice from, the 
Advisory Council for the Elimination of Tuberculosis (ACET); and (22) 
facilitates partnerships with affected communities, nongovernmental, 
professional, and global organizations.
    Office of the Director (CVJE1). (1) Provides leadership and 
guidance in program planning and management, policy formulation, and 
development of training, surveillance, and research programs in TB; (2) 
directs and evaluates the operations of the Division; (3) establishes 
contact with, and promotes TB activities of, other organizations that 
have an important role to play in achieving TB elimination; (4) 
coordinates administrative and logistical support services for the 
Division; (5) provides consultation and assistance in writing reports 
for presentation at local, regional, national, and international 
scientific meetings and for publication in scientific journals; (6) 
coordinates and tracks materials for purposes of clearance and approval 
for publications and presentations; (7) presents findings at national 
and international scientific meetings; (8) presents Division overview 
at the ACET meetings; (9) collaborates and coordinates Division 
activities with other components of NCHHSTP and CDC; (10) provides 
technical support to ACET; (11) provides administrative and technical 
support for STOP TB USA (previously the National Coalition for the 
Elimination of Tuberculosis) and the Federal TB Task Force; and (12) 
provides representation of the U.S. national TB program to WHO and 
other international entities.
    Communications, Education, and Behavioral Studies Branch (CVJEB). 
(1) Provides technical assistance to health departments and other 
health care providers in assessing and meeting their TB training, 
education, and communication needs; (2) provides technical expertise to 
assess the impact of training and education activities by health 
departments; (3) provides technical assistance to health departments 
and other TB health care providers regarding behavioral studies 
research and intervention development; (4) provides consultation and 
assistance in coordinating TB training, education, behavioral studies 
and interventions, and communication activities carried out by other 
CDC programs, Regional Training and Medical Consultation Centers, and 
Stop TB USA members, and develops, markets, and maintains electronic 
mailing lists for persons with TB-related education, training, and 
communication responsibilities; (5) provides DTBE coordination and 
oversight and technical information for CDC INFO; (6) organizes and 
maintains scientific and non-scientific information resources related 
to TB; (7) conducts formative research and evaluation on approaches to 
patient, provider, and public education, and conducts research on 
individual and social factors affecting health-care seeking behavior 
and treatment outcomes related to TB; (8) based on research findings, 
develops behavioral interventions targeted to health care providers, 
persons with or at risk for TB, and other high-risk populations; (9) 
provides consultation to national organizations on behavioral research 
needs and study designs; on the technical transfer of behavioral 
research findings into TB program practice and TB training and 
educational strategies; and provides consultation, technical assistance 
and coordination to other branches within the Division regarding 
development and implementation of behavioral interventions and training 
for branch specific activities such as Report of Verified Case of 
Tuberculosis, Aggregate Reports for Program Evaluation, and 
surveillance activities; (10) presents findings at national and 
international scientific meetings and develops, disseminates and 
evaluates training and

[[Page 54093]]

educational materials and courses providing TB information to the 
scientific and public health communities, as well as the general 
population; (11) conducts training and education needs assessments; 
identifies resources available for health department TB control 
officers and senior managers, TB nurse consultants, TB training and 
education directors and for senior staff carrying out TB activities in 
other programs or facilities serving persons at high risk for TB; and 
develops, conducts, and coordinates training courses on TB for state 
and big city TB program managers and nurse consultants; (12) based on 
needs assessments, develops and conducts or coordinates training 
courses and materials for staff who train and/or supervise front-line 
TB program staff; (13) provides oversight in the planning, 
coordination, and maintenance of the Division's Internet and Intranet 
Web sites; (14) conducts and/or coordinates communications programs 
designed to build public support and sustain public interest and 
commitment to the elimination of TB; (15) conducts communications 
research and identifies communications resources available for health 
department TB control officers and senior managers, TB nurse 
consultants, and for senior staff carrying out activities in other 
programs or facilities serving persons at high risk for TB; (16) 
provides coordination and oversight for Division responses and 
relations with the media and public and serves as point of contact for 
telephonic, written, and electronic (email) requests for information 
from the media and public; (17) develops, coordinates, and staffs the 
Division's exhibit booth at conferences/meetings; (18) provides 
oversight and coordination for TB-related voice and web-based TB 
information, training, and education resources; and (19) presents 
communications issues to ACET and at national and international 
scientific meetings.
    Data Management, Statistics, and Evaluation Branch (CVJEC). (1) 
Provides Division-wide leadership in and coordination of data 
management, statistics, program evaluation, and economic planning, 
policy development, and monitoring within an integrated systems 
framework, playing a central role in the education of all DTBE staff on 
the science and methods of data management, statistics, program 
evaluation, and health economics; (2) consults and assists in 
appropriate data collection, management, analysis, and reporting for 
scientific studies conducted Division-wide; (3) collaborates in the 
statistical analysis of data and in the preparation of materials for 
publication; (4) coordinates and oversees data management and 
statistical design, implementation and analysis support, and 
consultation for the TB Clinical Trials and the TB Epidemiologic 
Studies Consortia; (5) conducts statistical research and methods 
development, including mathematical models of TB transmission and 
diagnostic test performance to improve the effectiveness of prevention 
and control activities; (6) coordinates data management, statistics, 
and evaluation services provided under contractual services; (7) 
collaborates with other components of the Division to develop and 
implement strategies and activities to meet goals for Division 
priorities; (8) translates overall NCHHSTP and DTBE strategies into 
branch-specific implementation plans for research and programs; and (9) 
participates in the development of comprehensive evaluation methods for 
TB prevention and control programs; (10) consults on the implementation 
of key provisions of program evaluation contained in cooperative 
agreements between CDC and external state and local TB programs; (11) 
provides transparent and easily understood program evaluation and 
health economic data to TB control programs that serve them in meeting 
TB national goals and objectives; (12) galvanizes external TB control 
programs to implement and use National TB Indicators Project data to 
prioritize program areas for improvement; (13) provides major 
authoritative technical advice on economics and be an authority on all 
matters related to the analysis and collection of economic data 
relevant to Division goals, and (14) presents data management, 
statistical, and economic considerations, and reporting issues to ACET 
and other national and international scientific meetings.
    Field Services Branch (CVJED). (1) Provides medical and 
programmatic consultation to assist state and local health departments 
in developing, implementing and evaluating their activities toward 
achieving tuberculosis prevention, control, and elimination; (2) 
promotes adoption of CDC tuberculosis-related policies by national 
organizations, health departments, and health care providers; (3) 
provides consultation and assists state and local health departments in 
the methodology and application of tuberculosis control techniques 
recommended by CDC; (4) provides technical assistance to states and 
localities for improving program operations; (5) encourages and 
facilitates the transfer of new technology and guidelines into clinical 
and public health practice; (6) serves as a liaison or focal point to 
assist TB programs in state and local health departments in linking 
with proper resource persons and obtaining technical assistance, both 
within and outside the Division; (7) participates in development of 
national policies and guidelines for tuberculosis elimination; (8) 
identifies and facilitates sharing of best practices to ensure that 
good program methodology in one program is known and made available to 
other state and local programs; (9) serves as the lead branch for 
administration and management of cooperative agreement programs with 
state and local health department tuberculosis programs and others who 
support state and local health department tuberculosis programs; (10) 
develops funding opportunities based on Division strategic priorities; 
(11) coordinates technical reviews of cooperative agreement 
applications and makes appropriate funding recommendations; (12) 
monitors grantee performance on activities specified in the cooperative 
agreement; (13) identifies specific management, operational, and staff 
performance problems associated with not achieving TB control 
objectives or with not implementing essential TB components, and 
recommends solutions; (14) participates in the development of 
comprehensive evaluation methods for TB prevention and control 
programs; (15) collaborates with other DTBE branches in the evaluation 
of tuberculosis programs and development of program management and 
evaluation reports for publication; (16) provides supervision and 
support for the CDC field staff; (17) conducts a continuing analysis of 
the effectiveness of field personnel and utilization of other resources 
in relation to the tuberculosis problems; (18) provides input in to the 
development of Division policy, priorities and operational procedures; 
(19) provides programmatic oversight, technical assistance, and medical 
consultation to the Regional Training and Medical Consultation Centers; 
and (20) presents programmatic activities to ACET and at national and 
international scientific meetings.
    Clinical Research Branch (CVJEE). (1) Assesses the need for and 
conducts studies of new or existing drugs and regimens used in the 
prevention and treatment of TB, including dosage, duration, 
pharmacokinetics and toxicity; (2) supports the TB Trials Consortium in 
the conduct of studies of

[[Page 54094]]

new treatments for active TB and latent TB infection; (3) supports 
coordinated and standardized data management for branch research, and 
serves as the Data and Coordinating Center for the TB Trials 
Consortium, collaborating as needed with both internal and external 
partners; (4) provides clinical support and oversight for the 
distribution of investigational drugs for the treatment and prevention 
of TB by CIOs/Scientific Resources/Drug Service; (5) assesses the need 
for and conducts clinical and field trials of more specific and rapid 
tests to diagnose active TB and latent TB infection and to identify 
drug-resistant TB in collaboration with the Laboratory Branch; (6) 
collaborates with and provides consultation and technical assistance to 
national and international organizations on the design and conduct of 
clinical trials and research needs; (7) conducts, participates in, and 
collaborates with other DTBE units in research on clinical, 
epidemiologic, immunologic and genetic aspects of TB prevention and 
control; (8) collaborates with external partners in implementation of 
research; (9) maintains expertise and addresses special research needs 
relevant to drug pharmacokinetics, microbiology, drug resistant TB & 
special populations, including children and persons living with HIV; 
(10) provides consultation and training to local, state, national and 
international organizations and to TB program field staff, on design 
and conducts of clinical trials, TB therapeutics and diagnostics, 
health care systems research needs, decision and economic analyses, 
evaluation techniques, qualitative research methods, and research on TB 
transmission; (11) has responsibility for Divisional engagement in 
preparing for and participating in trials of new TB vaccines and when 
appropriate, collaborates with private and public institutions in the 
area of vaccine development; (12) reports study results to public 
health practitioners through direct communication, articles in 
scientific journals and CDC publications, and oral and poster 
presentations at national and international scientific and program 
meetings; (13) provides input into statements and guidelines issued by 
the CDC, the ACET, and professional organizations; and (14) presents 
research issues and findings to ACET and at national and international 
scientific meetings.
    Surveillance, Epidemiology, and Outbreak Investigations Branch 
(CVJEG). (1) Directs national surveillance of tuberculosis to provide 
accurate and timely national data and to monitor progress toward the 
elimination of tuberculosis in the U.S.; (2) conducts analyses of 
national TB surveillance data to monitor national trends in TB in order 
to assist n program planning, evaluation, and policy development and to 
identify areas for further study to guide elimination efforts; (3) 
conducts surveillance-related studies that evaluate current TB 
surveillance systems and develops new surveillance methods and systems 
in order to better monitor and accelerate TB elimination efforts; (4) 
provides technical surveillance expertise to state and local TB control 
programs, other federal agencies, and other organizations involved in 
TB prevention and control; (5) conducts epidemiologic research to 
assess the characteristics of persons with M. tuberculosis disease and 
infection in the U.S.; (6) analyzes research findings to develop 
improved interventions for eliminating tuberculosis and better analytic 
tools for future studies; (7) provides technical epidemiologic 
expertise to state and local tuberculosis control programs; (8) 
supports the TB Epidemiologic Studies Consortium in the conduct of 
studies of programmatically relevant epidemiologic, behavioral, 
economic, laboratory, and operational research concerning the 
identification, diagnosis, prevention and control of TB disease and 
latent infection; (9) conducts molecular epidemiologic analyses of TB 
cases to identify, track, and guide interventions to stop TB outbreaks; 
(10) investigates outbreaks of tuberculosis; (11) provides consultation 
and technical expertise on TB surveillance, epidemiology and outbreaks 
to state and local tuberculosis control programs; (12) analyzes TB 
outbreak investigation findings in order to improve the ability of 
tuberculosis control programs to detect future outbreaks and respond to 
them promptly and appropriately to limit transmission; (13) supervises 
EIS officers in the conduct of their two-year assignments; (14) 
prepares manuscripts for publication in scientific journals; (15) 
presents findings at national and international scientific meetings; 
and (16) presents surveillance, epidemiology, and outbreak findings to 
ACET and at national and international scientific meetings
    Laboratory Branch (CVJEJ). (1) Serves as the national reference 
laboratory in support of the mission of DTBE, fulfilling public health 
function in leadership, clinical and consultative service, and 
research; (2) provides laboratory support for epidemiological 
investigations, surveillance activities, and special studies of 
Mycobacterium tuberculosis, in collaboration with other branches; (3) 
administers contracts to provide M. tuberculosis genotyping, maintains 
a national database of genotypes, and conducts operational research to 
evaluate genotyping and optimize use of state-of-the-art methods; (4) 
serves as primary CDC source for reference laboratory services for M. 
tuberculosis; (5) administers grants and cooperative agreements to 
strengthen laboratory activities and advance testing services; (6) 
provides consultation, technical assistance, and training to state and 
municipal public health laboratories; (7) develops, evaluates, or 
improves conventional and molecular methods for the detection, 
characterization, and susceptibility testing of M. tuberculosis; (8) 
conducts studies to define the role of bacterial virulence factors and 
host factors in disease processes and protection, and develops, 
evaluates, and improves methods for the diagnosis and prevention of TB; 
(9) develops experimental models of TB and conducts studies on therapy, 
pathogenesis, and prevention for TB; (10) prepares manuscripts for 
publication in scientific journals; (11) presents findings at national 
and international scientific meetings; (12) supervises and trains 
fellows in temporary or multi-year educationally-based programs in 
areas related to the mission of the branch; and (13) elevates awareness 
of laboratory issues to ACET and other stakeholders.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2016-19302 Filed 8-12-16; 8:45 am]
 BILLING CODE 4160-18-P

Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices 54091 10% are non-GLBA entities (6,275), and burden hours for the FTC, staff added Postal mail addressed to the 90% are GLBA entities (56,475). the costs associated with motor vehicle Commission is subject to delay due to Applying an assumed rate of affiliation dealers ($501,032), resulting in a total heightened security screening. As a of 16.75%, staff estimates that there are cost burden for the FTC of $18,472,938. result, we encourage you to submit your 1,051 non-GLBA and 9,460 GLBA motor comments online. To make sure that the Request for Comment vehicle dealerships in affiliated Commission considers your online families. Staff further assumes there are You can file a comment online or on comment, you must file it at https:// an average of 5 businesses per family or paper. For the Commission to consider public.commentworks.com/ftc/ affiliated relationship, leaving your comment, we must receive it on or affiliatemarketingpra by following the approximately 210 non-GLBA and 1,892 before October 14, 2016. Write ‘‘Affiliate instructions on the web-based form. If GLBA motor vehicle dealership Marketing Disclosure Rule, PRA this Notice appears at http:// families, respectively. Comment: FTC File No. P0105411’’ on www.regulations.gov/#!home, you also Staff further estimates that non-GLBA your comment. Your comment, may file a comment through that Web business families will spend 14 hours in including your name and your state— site. the first year and 0 hours thereafter to will be placed on the public record of If you file your comment on paper, comply with the Rule, while GLBA this proceeding, including, to the extent write ‘‘Affiliate Marketing Disclosure business families will spend 6 hours in practicable, on the public Commission Rule, PRA Comment: FTC File No. the first year, and 4 hours in each of the Web site, at http://www.ftc.gov/os/ P0105411’’ on your comment, and on following two years. The cumulative publiccomments.shtm. As a matter of the envelope, and mail or deliver it to average annual burden for the non- discretion, the Commission tries to the following address: Federal Trade GLBA and GLBA motor vehicle remove individuals’ home contact Commission, Office of the Secretary, dealership families is 9,809 hours.20 information from comments before 600 Pennsylvania Avenue NW., Suite To calculate the FTC’s total shared placing them on the Commission Web CC–5610 (Annex J), Washington, DC burden hours, staff deducted from site. 20580, or deliver your comment to the overall estimated burden hours (910,602 Because your comment will be made following address: Federal Trade hours) the hours attributed to motor public, you are solely responsible for Commission, Office of the Secretary, vehicle dealerships (9,809 hours), making sure that your comment doesn’t Constitution Center, 400 7th Street SW., leaving a total of 900,793 hours to split include any sensitive personal 5th Floor, Suite 5610 (Annex J), between the CFPB and the FTC. The information, like anyone’s Social Washington, DC 20024. If possible, resulting shared burden for the CFPB is Security number, date of birth, driver’s submit your paper comment to the half that amount, or 450,396 hours. To license number or other state Commission by courier or overnight calculate the total burden hours identification number or foreign country service. apportioned to the FTC, staff added to equivalent, passport number, financial The FTC Act and other laws that the the shared sub-total (450,396 hours) the account number, or credit or debit card Commission administers permit the hours separately attributed to motor number. You are also solely responsible collection of public comments to vehicle dealers (9,809 hours), which for making sure that your comment consider and use in this proceeding as yields for the FTC an apportioned doesn’t include any sensitive health appropriate. The Commission will burden estimate of 460,205 hours. information, like medical records or consider all timely and responsive Staff used the same approach to other individually identifiable health public comments that it receives on or estimate the shared costs for the FTC. information. In addition, don’t include before October 14, 2016. For Staff estimated the costs attributed to any ‘‘[t]rade secret or any commercial or information on the Commission’s motor vehicle dealers as follows: Non- financial information which is . . . privacy policy, including routine uses GLBA business families have privileged or confidential,’’ as provided permitted by the Privacy Act, see http:// $35,626,785 in annualized labor costs,21 in Section 6(f) of the FTC Act, 15 U.S.C. www.ftc.gov/ftc/privacy.htm. and GLBA business families have 46(f), and FTC Rule 4.10(a)(2), 16 CFR David C. Shonka, $818,059 in annualized labor costs,22 for 4.10(a)(2). In particular, don’t include cumulative annualized costs of Acting General Counsel. competitively sensitive information $36,444,844. such as costs, sales statistics, [FR Doc. 2016–19226 Filed 8–12–16; 8:45 am] To calculate, on an annualized basis, inventories, formulas, patterns, devices, BILLING CODE 6750–01–P the FTC’s cumulative share of labor cost manufacturing processes, or customer burden, staff deducted from overall total names. labor costs ($36,444,844) the labor costs If you want the Commission to give DEPARTMENT OF HEALTH AND attributed to motor vehicle dealerships your comment confidential treatment, HUMAN SERVICES ($501,032), leaving a net amount of you must file it in paper form, with a $35,943,812 to split between the CFPB request for confidential treatment, and Centers for Disease Control and and the FTC. The resulting shared you have to follow the procedure Prevention burden for the CFPB is half that amount, explained in FTC Rule 4.9(c), 16 CFR or $17,971,906. To calculate the total Statement of Organization, Functions, 4.9(c).23 Your comment will be kept and Delegations of Authority confidential only if the FTC General dealers) (81 FR 33,255 at 33,257 n9 (May 25, 2016) Counsel grants your request in Part C (Centers for Disease Control (FTC Prescreen Opt-Out Rule PRA analysis). accordance with the law and the public and Prevention) of the Statement of sradovich on DSK3GMQ082PROD with NOTICES 20 (210 non-GLBA business families × 4.666667 average hours = 980 hours, annualized) + (1,892 interest. Organization, Functions, and GLBA business families × 4.666667 average hours Delegations of Authority of the per family = 8,829 hours, annualized) = 9,809 23 In particular, the written request for Department of Health and Human hours, annualized. confidential treatment that accompanies the 21 191,779 non-GLBA business families × Services (45 FR 67772–76, dated comment must include the actual and legal basis for combined rate of $557.31 (see supra note 13) ÷ 3 the request, and must identify the specific portions October 14, 1980, and corrected at 45 FR = $35,626,785. of the comment to be withheld from the public 69296, October 20, 1980, as amended 22 See supra note 18. record. See FTC Rule 4.9(c), 16 CFR 4.9(c). most recently at 81 FR 46677, dated July VerDate Sep<11>2014 19:23 Aug 12, 2016 Jkt 238001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1

54092 Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices 18, 2016) is amended to reflect the laboratory, diagnostics, clinical, and CDC; (10) provides technical support to reorganization of the Division of vaccine development research; (12) ACET; (11) provides administrative and Tuberculosis Elimination, National develops and applies mathematical TB technical support for STOP TB USA Center for HIV/AIDS, Viral Hepatitis, transmission models to forecast future (previously the National Coalition for STD, and TB Prevention, Office of incidence and prevalence trends; (13) the Elimination of Tuberculosis) and the Infectious Diseases, Centers for Disease provides leadership and formulates Federal TB Task Force; and (12) Control and Prevention. policies and guidelines; (14) provides provides representation of the U.S. Section C–B, Organization and technical supervision and training to national TB program to WHO and other Functions, is hereby amended as federal assignees working in state, and international entities. follows: local TB control programs; (15) develops Communications, Education, and Delete and replace the title and the training and educational materials, and Behavioral Studies Branch (CVJEB). (1) mission and function statements for the provides technical assistance on Provides technical assistance to health Division of Tuberculosis Elimination communications and training needs; departments and other health care (CVJE) and insert the following: (16) participates in the development of providers in assessing and meeting their Division of Tuberculosis Elimination policies and guidelines for TB (CVJE). The Division of Tuberculosis TB training, education, and prevention and control within communication needs; (2) provides Elimination (DTBE) promotes health populations at high risk, such as and quality of life by preventing, technical expertise to assess the impact persons infected with HIV or racial and of training and education activities by controlling, and eventually eliminating ethnic minorities; (17) supports tuberculosis (TB) from the United States health departments; (3) provides technical activities and operational technical assistance to health (U.S.), and collaborates with research to reduce TB in foreign-born international partners by representing departments and other TB health care populations; (18) Represents the U.S. providers regarding behavioral studies the U.S. national TB program. In national TB program with regard to the carrying out its mission, the Division research and intervention development; global health initiatives for the (4) provides consultation and assistance conducts the following activities under prevention and control of TB and drug- each focus area: (1) Administers and in coordinating TB training, education, resistant TB; (19) Represents the U.S. behavioral studies and interventions, promotes a national program for the national TB control program with regard and communication activities carried prevention, control, and elimination of to the World Health Organization out by other CDC programs, Regional TB; (2) supports a nationwide (WHO)-hosted Stop TB Partnership for Training and Medical Consultation framework for surveillance of TB and implementation of the Global Plan to Centers, and Stop TB USA members, evaluation of national TB prevention Stop TB and Millennium Development and develops, markets, and maintains and control performance; (3) provides Goals; (20) monitors progress and trends electronic mailing lists for persons with programmatic consultation, technical towards TB elimination, including TB-related education, training, and assistance, and outbreak response progress towards CDC’s Healthy People communication responsibilities; (5) assistance to state and local TB programs; (4) co-chairs and coordinates 2020; (21) provides progress reports to, provides DTBE coordination and administrative support for the Federal and solicits advice from, the Advisory oversight and technical information for TB Task Force, and supports and Council for the Elimination of CDC INFO; (6) organizes and maintains collaborates with the National Tuberculosis (ACET); and (22) facilitates scientific and non-scientific information Tuberculosis Controllers Association partnerships with affected communities, resources related to TB; (7) conducts (NTCA) and the Tuberculosis Education nongovernmental, professional, and formative research and evaluation on and Training Network to promote global organizations. approaches to patient, provider, and effective national communications and Office of the Director (CVJE1). (1) public education, and conducts research coordinated feedback on urgent policy Provides leadership and guidance in on individual and social factors and program performance issues; (5) program planning and management, affecting health-care seeking behavior supports development of TB patient policy formulation, and development of and treatment outcomes related to TB; education materials and interventions, training, surveillance, and research (8) based on research findings, develops capacity development, and access to programs in TB; (2) directs and behavioral interventions targeted to medical consultation; (6) provides evaluates the operations of the Division; health care providers, persons with or at national and supranational reference (3) establishes contact with, and risk for TB, and other high-risk laboratory function for identification promotes TB activities of, other populations; (9) provides consultation and drug susceptibility testing of organizations that have an important to national organizations on behavioral Mycobacterium tuberculosis; (7) fosters role to play in achieving TB elimination; research needs and study designs; on patient-centered messages, including (4) coordinates administrative and the technical transfer of behavioral those regarding directly-observed logistical support services for the research findings into TB program therapy, to promote adherence with Division; (5) provides consultation and practice and TB training and long-term treatment for improvements assistance in writing reports for educational strategies; and provides in well-being and interruption in presentation at local, regional, national, consultation, technical assistance and community transmission of M. and international scientific meetings coordination to other branches within tuberculosis; (8) promotes targeted and for publication in scientific the Division regarding development and testing of epidemiologically-defined at- journals; (6) coordinates and tracks implementation of behavioral risk populations and treatment of materials for purposes of clearance and interventions and training for branch sradovich on DSK3GMQ082PROD with NOTICES persons with latent TB; (9) conducts approval for publications and specific activities such as Report of epidemiologic, laboratory, behavioral, presentations; (7) presents findings at Verified Case of Tuberculosis, Aggregate health systems, and clinical research; national and international scientific Reports for Program Evaluation, and (10) supports patient and provider meetings; (8) presents Division overview surveillance activities; (10) presents research to identify barriers and at the ACET meetings; (9) collaborates findings at national and international facilitators to TB services; (11) supports and coordinates Division activities with scientific meetings and develops, multicenter consortia for epidemiologic, other components of NCHHSTP and disseminates and evaluates training and VerDate Sep<11>2014 19:23 Aug 12, 2016 Jkt 238001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1

Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices 54093 educational materials and courses collaborates in the statistical analysis of operations; (5) encourages and providing TB information to the data and in the preparation of materials facilitates the transfer of new technology scientific and public health for publication; (4) coordinates and and guidelines into clinical and public communities, as well as the general oversees data management and health practice; (6) serves as a liaison or population; (11) conducts training and statistical design, implementation and focal point to assist TB programs in state education needs assessments; identifies analysis support, and consultation for and local health departments in linking resources available for health the TB Clinical Trials and the TB with proper resource persons and department TB control officers and Epidemiologic Studies Consortia; (5) obtaining technical assistance, both senior managers, TB nurse consultants, conducts statistical research and within and outside the Division; (7) TB training and education directors and methods development, including participates in development of national for senior staff carrying out TB activities mathematical models of TB policies and guidelines for tuberculosis in other programs or facilities serving transmission and diagnostic test elimination; (8) identifies and facilitates persons at high risk for TB; and performance to improve the sharing of best practices to ensure that develops, conducts, and coordinates effectiveness of prevention and control good program methodology in one training courses on TB for state and big activities; (6) coordinates data program is known and made available to city TB program managers and nurse management, statistics, and evaluation other state and local programs; (9) consultants; (12) based on needs services provided under contractual serves as the lead branch for assessments, develops and conducts or services; (7) collaborates with other administration and management of coordinates training courses and components of the Division to develop cooperative agreement programs with materials for staff who train and/or and implement strategies and activities state and local health department supervise front-line TB program staff; to meet goals for Division priorities; (8) tuberculosis programs and others who (13) provides oversight in the planning, translates overall NCHHSTP and DTBE support state and local health coordination, and maintenance of the strategies into branch-specific department tuberculosis programs; (10) Division’s Internet and Intranet Web implementation plans for research and develops funding opportunities based sites; (14) conducts and/or coordinates programs; and (9) participates in the on Division strategic priorities; (11) communications programs designed to development of comprehensive coordinates technical reviews of build public support and sustain public evaluation methods for TB prevention cooperative agreement applications and interest and commitment to the and control programs; (10) consults on makes appropriate funding elimination of TB; (15) conducts the implementation of key provisions of recommendations; (12) monitors grantee communications research and identifies program evaluation contained in performance on activities specified in communications resources available for cooperative agreements between CDC the cooperative agreement; (13) health department TB control officers and external state and local TB identifies specific management, and senior managers, TB nurse programs; (11) provides transparent and operational, and staff performance consultants, and for senior staff carrying easily understood program evaluation problems associated with not achieving out activities in other programs or and health economic data to TB control TB control objectives or with not facilities serving persons at high risk for programs that serve them in meeting TB implementing essential TB components, TB; (16) provides coordination and national goals and objectives; (12) and recommends solutions; (14) oversight for Division responses and galvanizes external TB control programs participates in the development of relations with the media and public and to implement and use National TB comprehensive evaluation methods for serves as point of contact for telephonic, Indicators Project data to prioritize TB prevention and control programs; written, and electronic (email) requests program areas for improvement; (13) (15) collaborates with other DTBE for information from the media and provides major authoritative technical branches in the evaluation of public; (17) develops, coordinates, and advice on economics and be an tuberculosis programs and development staffs the Division’s exhibit booth at authority on all matters related to the of program management and evaluation conferences/meetings; (18) provides analysis and collection of economic data reports for publication; (16) provides oversight and coordination for TB- relevant to Division goals, and (14) supervision and support for the CDC related voice and web-based TB presents data management, statistical, field staff; (17) conducts a continuing information, training, and education and economic considerations, and analysis of the effectiveness of field resources; and (19) presents reporting issues to ACET and other personnel and utilization of other communications issues to ACET and at national and international scientific resources in relation to the tuberculosis national and international scientific meetings. problems; (18) provides input in to the meetings. Field Services Branch (CVJED). (1) development of Division policy, Data Management, Statistics, and Provides medical and programmatic priorities and operational procedures; Evaluation Branch (CVJEC). (1) Provides consultation to assist state and local (19) provides programmatic oversight, Division-wide leadership in and health departments in developing, technical assistance, and medical coordination of data management, implementing and evaluating their consultation to the Regional Training statistics, program evaluation, and activities toward achieving tuberculosis and Medical Consultation Centers; and economic planning, policy prevention, control, and elimination; (2) (20) presents programmatic activities to development, and monitoring within an promotes adoption of CDC tuberculosis- ACET and at national and international integrated systems framework, playing a related policies by national scientific meetings. central role in the education of all DTBE organizations, health departments, and Clinical Research Branch (CVJEE). (1) sradovich on DSK3GMQ082PROD with NOTICES staff on the science and methods of data health care providers; (3) provides Assesses the need for and conducts management, statistics, program consultation and assists state and local studies of new or existing drugs and evaluation, and health economics; (2) health departments in the methodology regimens used in the prevention and consults and assists in appropriate data and application of tuberculosis control treatment of TB, including dosage, collection, management, analysis, and techniques recommended by CDC; (4) duration, pharmacokinetics and reporting for scientific studies provides technical assistance to states toxicity; (2) supports the TB Trials conducted Division-wide; (3) and localities for improving program Consortium in the conduct of studies of VerDate Sep<11>2014 19:23 Aug 12, 2016 Jkt 238001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1

54094 Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices new treatments for active TB and latent accurate and timely national data and to and special studies of Mycobacterium TB infection; (3) supports coordinated monitor progress toward the elimination tuberculosis, in collaboration with other and standardized data management for of tuberculosis in the U.S.; (2) conducts branches; (3) administers contracts to branch research, and serves as the Data analyses of national TB surveillance provide M. tuberculosis genotyping, and Coordinating Center for the TB data to monitor national trends in TB in maintains a national database of Trials Consortium, collaborating as order to assist n program planning, genotypes, and conducts operational needed with both internal and external evaluation, and policy development and research to evaluate genotyping and partners; (4) provides clinical support to identify areas for further study to optimize use of state-of-the-art methods; and oversight for the distribution of guide elimination efforts; (3) conducts (4) serves as primary CDC source for investigational drugs for the treatment surveillance-related studies that reference laboratory services for M. and prevention of TB by CIOs/Scientific evaluate current TB surveillance tuberculosis; (5) administers grants and Resources/Drug Service; (5) assesses the systems and develops new surveillance cooperative agreements to strengthen need for and conducts clinical and field methods and systems in order to better laboratory activities and advance testing trials of more specific and rapid tests to monitor and accelerate TB elimination services; (6) provides consultation, diagnose active TB and latent TB efforts; (4) provides technical technical assistance, and training to infection and to identify drug-resistant surveillance expertise to state and local state and municipal public health TB in collaboration with the Laboratory TB control programs, other federal laboratories; (7) develops, evaluates, or Branch; (6) collaborates with and agencies, and other organizations improves conventional and molecular provides consultation and technical involved in TB prevention and control; methods for the detection, assistance to national and international (5) conducts epidemiologic research to characterization, and susceptibility organizations on the design and conduct assess the characteristics of persons testing of M. tuberculosis; (8) conducts of clinical trials and research needs; (7) with M. tuberculosis disease and studies to define the role of bacterial conducts, participates in, and infection in the U.S.; (6) analyzes virulence factors and host factors in collaborates with other DTBE units in research findings to develop improved disease processes and protection, and research on clinical, epidemiologic, interventions for eliminating develops, evaluates, and improves immunologic and genetic aspects of TB tuberculosis and better analytic tools for methods for the diagnosis and prevention and control; (8) collaborates future studies; (7) provides technical prevention of TB; (9) develops with external partners in epidemiologic expertise to state and experimental models of TB and implementation of research; (9) local tuberculosis control programs; (8) conducts studies on therapy, maintains expertise and addresses supports the TB Epidemiologic Studies pathogenesis, and prevention for TB; special research needs relevant to drug Consortium in the conduct of studies of (10) prepares manuscripts for pharmacokinetics, microbiology, drug programmatically relevant publication in scientific journals; (11) resistant TB & special populations, epidemiologic, behavioral, economic, presents findings at national and including children and persons living laboratory, and operational research international scientific meetings; (12) with HIV; (10) provides consultation concerning the identification, diagnosis, supervises and trains fellows in and training to local, state, national and prevention and control of TB disease temporary or multi-year educationally- international organizations and to TB and latent infection; (9) conducts based programs in areas related to the program field staff, on design and molecular epidemiologic analyses of TB mission of the branch; and (13) elevates conducts of clinical trials, TB cases to identify, track, and guide awareness of laboratory issues to ACET therapeutics and diagnostics, health interventions to stop TB outbreaks; (10) and other stakeholders. care systems research needs, decision investigates outbreaks of tuberculosis; Sherri Berger, and economic analyses, evaluation (11) provides consultation and technical Chief Operating Officer, Centers for Disease techniques, qualitative research expertise on TB surveillance, Control and Prevention. methods, and research on TB epidemiology and outbreaks to state and [FR Doc. 2016–19302 Filed 8–12–16; 8:45 am] transmission; (11) has responsibility for local tuberculosis control programs; (12) BILLING CODE 4160–18–P Divisional engagement in preparing for analyzes TB outbreak investigation and participating in trials of new TB findings in order to improve the ability vaccines and when appropriate, of tuberculosis control programs to DEPARTMENT OF HEALTH AND collaborates with private and public detect future outbreaks and respond to HUMAN SERVICES institutions in the area of vaccine them promptly and appropriately to development; (12) reports study results limit transmission; (13) supervises EIS Centers for Disease Control and to public health practitioners through officers in the conduct of their two-year Prevention direct communication, articles in assignments; (14) prepares manuscripts [CDC–2016–0067, Docket Number NIOSH scientific journals and CDC for publication in scientific journals; 270–A] publications, and oral and poster (15) presents findings at national and presentations at national and international scientific meetings; and NIOSH Center for Motor Vehicle Safety: international scientific and program (16) presents surveillance, Midcourse Review of Strategic Plan meetings; (13) provides input into epidemiology, and outbreak findings to AGENCY: National Institute for statements and guidelines issued by the ACET and at national and international Occupational Safety and Health CDC, the ACET, and professional scientific meetings (NIOSH) of the Centers for Disease organizations; and (14) presents Laboratory Branch (CVJEJ). (1) Serves sradovich on DSK3GMQ082PROD with NOTICES Control and Prevention (CDC), research issues and findings to ACET as the national reference laboratory in Department of Health and Human and at national and international support of the mission of DTBE, Services (HHS). scientific meetings. fulfilling public health function in ACTION: Notice of public web meeting Surveillance, Epidemiology, and leadership, clinical and consultative and request for comment. Outbreak Investigations Branch service, and research; (2) provides (CVJEG). (1) Directs national laboratory support for epidemiological SUMMARY: The National Institute for surveillance of tuberculosis to provide investigations, surveillance activities, Occupational Safety and Health of the VerDate Sep<11>2014 19:23 Aug 12, 2016 Jkt 238001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1


Document Created: 2016-08-13 02:22:44
Document Modified: 2016-08-13 02:22:44
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation81 FR 54091 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR